a b s t r a c tSince their discovery as cellular counterparts of viral oncogenes more than two decades ago, enormous progress has been made in unraveling the complex regulatory pathways of signal transduction initiated by the Crk family of proteins. New structural and biochemical studies have uncovered novel insights into both negative and positive regulation of Crk mediated by its atypical carboxylterminal SH3 domain (SH3C). Moreover, SH3C is tyrosine phosphorylated by receptor tyrosine kinases and non-receptor tyrosine kinases, thereby permitting assemblages of other SH2/PTB domain containing proteins. Such non-canonical signaling by the Crk SH3C reveals new regulatory strategies for adaptor proteins.Ó 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.Named for their ability to elevate cellular tyrosine phosphorylation and transform primary chicken embryo fibroblasts (CEFs) [1], CT10 regulator of kinase (Crk) is the prototypical member of a class of Src Homology-2 (SH2) and Src Homology-3 (SH3) domain-containing proteins that lack intrinsic enzymatic activity but instead function to promote protein-protein interactions [2,3]. Over the past two decades, enormous progress in our understanding of signal transduction has emerged from studies on Crk. The canonical signaling pathway, defined by recognition of specific phosphotyrosine motifs by the SH2 domain (in the context of p-Tyr.X.X.Pro) [4] and Polyproline Type II motifs by the N-terminal SH3 domain {in the context of Pro. X. X. Pro. X. (Lys/Arg)} [5], identified Crk as a connector between Receptor Tyrosine Kinases (RTKs) and/or their substrates and GTPase effector pathways (Fig. 1). Along with efforts on Grb2 [6], these insights were instrumental in defining missing links between integrins and/or tyrosine phosphorylated growth factor receptors and downstream effector pathways that regulate growth and differentiation, and also more generally for defining elements of modular domains in signaling. In recent years, new layers of regulation for Crk have emerged, pointing to not only unusual levels of auto-inhibition mediated by its atypical carboxylterminal SH3 domain, but also unexpected features of SH3 domain signaling that activate non-canonical pathways.CrkII and CrkL each contain an atypical C-terminal SH3 domain (SH3C), defined by its inability to bind to Polyproline Type II (PPII) motifs [7,22]. In both proteins, the atypical SH3 domain retains core structural characteristics of SH3 domains, consisting of a five-stranded b-barrel which forms the standard SH3 fold. However, the aromatic amino acids -F141, W169, Y186 which line the canonical PPII binding pocket on the Crk SH3N and are conserved in conventional SH3 domains, are replaced by polar residues -Q244, Q274 and H290 on the SH3C surface (Fig. 2), thereby rationalizing the drastically reduced affinity of this domain for proline rich sequences.The carboxyl-terminal region of Crk is considered inhibitory, since it contains elements that constrain binding to the N-terminal SH2 and...